C. Françès

6.5k total citations
200 papers, 3.4k citations indexed

About

C. Françès is a scholar working on Rheumatology, Pathology and Forensic Medicine and Dermatology. According to data from OpenAlex, C. Françès has authored 200 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 71 papers in Rheumatology, 45 papers in Pathology and Forensic Medicine and 44 papers in Dermatology. Recurrent topics in C. Françès's work include Systemic Lupus Erythematosus Research (36 papers), Autoimmune Bullous Skin Diseases (23 papers) and Systemic Sclerosis and Related Diseases (21 papers). C. Françès is often cited by papers focused on Systemic Lupus Erythematosus Research (36 papers), Autoimmune Bullous Skin Diseases (23 papers) and Systemic Sclerosis and Related Diseases (21 papers). C. Françès collaborates with scholars based in France, Spain and Switzerland. C. Françès's co-authors include S Boisnic, L. Robert, M.C. Branchet, P Godeau, J.C. Piette, A.M. Robert, B. Wechsler, Stéphane Barète, P. Cacoub and Loı̈c Guillevin and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Investigation and The Journal of Immunology.

In The Last Decade

C. Françès

183 papers receiving 3.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
C. Françès France 35 1.1k 706 664 643 643 200 3.4k
Camille Françès France 36 1.1k 1.1× 1.0k 1.4× 487 0.7× 862 1.3× 806 1.3× 120 4.0k
Erkan Alpsoy Türkiye 34 1.4k 1.4× 626 0.9× 534 0.8× 810 1.3× 637 1.0× 132 3.9k
P J Roberts-Thomson Australia 38 1.5k 1.4× 1.0k 1.5× 438 0.7× 541 0.8× 886 1.4× 185 4.0k
Manfred Zierhut Germany 34 1.4k 1.3× 359 0.5× 312 0.5× 661 1.0× 484 0.8× 227 4.9k
Norbert Sepp Austria 35 824 0.8× 749 1.1× 606 0.9× 299 0.5× 441 0.7× 115 3.5k
Claudio Lunardi Italy 34 1.0k 1.0× 615 0.9× 429 0.6× 369 0.6× 776 1.2× 130 4.3k
B. Granel France 28 563 0.5× 995 1.4× 461 0.7× 490 0.8× 435 0.7× 200 2.9k
Stefano Bombardieri Italy 30 883 0.8× 804 1.1× 264 0.4× 290 0.5× 522 0.8× 88 3.3k
Carlo Chizzolini Switzerland 38 832 0.8× 1.3k 1.9× 664 1.0× 539 0.8× 701 1.1× 162 4.9k
Dilia Giuggioli Italy 30 840 0.8× 2.1k 3.0× 948 1.4× 724 1.1× 971 1.5× 150 4.0k

Countries citing papers authored by C. Françès

Since Specialization
Citations

This map shows the geographic impact of C. Françès's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Françès with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Françès more than expected).

Fields of papers citing papers by C. Françès

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. Françès. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Françès. The network helps show where C. Françès may publish in the future.

Co-authorship network of co-authors of C. Françès

This figure shows the co-authorship network connecting the top 25 collaborators of C. Françès. A scholar is included among the top collaborators of C. Françès based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. Françès. C. Françès is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ochenduszko, Sebastián, et al.. (2024). Cytokine release syndrome and immune effector cell‑associated neurotoxicity syndrome in a melanoma patient treated with adjuvant pembrolizumab. Experimental and Therapeutic Medicine. 28(5). 423–423.
2.
Guettrot-Imbert, G., Nathalie Morel, Véronique Le Guern, et al.. (2016). Pregnancy and contraception in systemic and cutaneous lupus erythematosus. Annales de Dermatologie et de Vénéréologie. 143(10). 590–600. 9 indexed citations
3.
Lebrun‐Vignes, Bénédicte, et al.. (2015). Urticaire bleue aiguë après injection sous-cutanée de bleu patenté. Annales de Dermatologie et de Vénéréologie. 142(11). 670–674. 4 indexed citations
4.
Françès, C., et al.. (2014). Régression clinique et capillaroscopique après autogreffe de moelle d’une sclérodermie systémique cutanée limitée associée à un lymphome anaplasique CD30. Annales de Dermatologie et de Vénéréologie. 141(6-7). 446–451. 4 indexed citations
5.
Françès, C., Stéphane Barète, & A. Soria. (2011). Manifestations dermatologiques du syndrome des antiphospholipides. La Revue de Médecine Interne. 33(4). 200–205. 14 indexed citations
6.
Nicolau, Joana, et al.. (2011). Prevalence of depressive syndrome in type 2 diabetes. Sociodemographic, clinical and biochemical differences. 26. 2 indexed citations
7.
Barète, Stéphane, C. Françès, Frédéric Charlotte, et al.. (2009). Fatal Outcome of Deep-penetrating Lower Limb Primary Cutaneous Anaplastic Large Cell Lymphomas in Two Immunocompromised Patients. Acta Dermato Venereologica. 89(6). 627–630. 4 indexed citations
8.
Soria, A., et al.. (2008). Treatment of Refractory Oral Erosive Lichen Planus with Topical Rapamycin: 7 Cases. Dermatology. 218(1). 22–25. 41 indexed citations
9.
Monsel, Gentiane, E. Maubec, C. Picard‐Dahan, et al.. (2007). Anévrysmes aortiques multiples au cours d’une polychondrite atrophiante. Annales de Dermatologie et de Vénéréologie. 134(6-7). 552–554. 4 indexed citations
10.
André, M., I. Delèvaux, M. D’Incan, et al.. (2001). Apport de la tomodensitométrie abdominopelvienne dans le purpura rhumatoïde de l’adulte. La Revue de Médecine Interne. 22(2). 132–140. 2 indexed citations
11.
Dalac, S., A. Dompmartin, S Louvet, et al.. (2000). [Melanoma in organ transplant patients].. PubMed. 127(2). 160–5. 33 indexed citations
12.
Chosidow, O., et al.. (1997). La maladie de Degos. Annales de Dermatologie et de Vénéréologie. 124(3). 273–279. 3 indexed citations
13.
Papo, T., et al.. (1996). Étude de la molécule Fas soluble et membranaire dans le lupus systémique (LS) et le syndrome des antiphospholipides (SAPL) primaire. 147(7). 490–491. 1 indexed citations
14.
Huong, D. Lê Thi, B. Wechsler, J.C. Piette, et al.. (1995). RISKS OF OVULATION-INDUCTION THERAPY IN SYSTEMIC LUPUS ERYTHEMATOSUS. Lara D. Veeken. 35(11). 1184–1186. 34 indexed citations
15.
Pelletier, S., O. Chosidow, O. Rogeaux, et al.. (1995). [Probable antiphospholipid syndrome, secondary to fascioliasis].. PubMed. 146(4). 276–8. 5 indexed citations
16.
Arock, Michel, Liliane Le Goff, C. Françès, et al.. (1994). Anti-proliferative effects of CD23 ligation on normal human keratinocytes: Involvement of TNF-α and nitric oxide. Journal of Investigative Dermatology. 103(3). 422. 1 indexed citations
17.
Bécherel, Pierre‐André, M. Djavad Mossalayi, F Ouaaz, et al.. (1994). Involvement of cyclic AMP and nitric oxide in immunoglobulin E-dependent activation of Fc epsilon RII/CD23+ normal human keratinocytes.. Journal of Clinical Investigation. 93(5). 2275–2279. 45 indexed citations
18.
Bécherel, Pierre‐André, M. Djavad Mossalayi, Liliane Le Goff, et al.. (1994). Retinoids exert anti-inflammatory effects on human keratinocytes through inhibition of NO and TNF-α secretion. Journal of Investigative Dermatology. 103(3). 422. 7 indexed citations
19.
Françès, C., J.C. Pietté, Jean‐Paul Viard, et al.. (1992). Anticorps anti-phospholipides et anti-β2 glycoprotéine dans le syndrome de Sneddon. À propos de 16 cas. La Revue de Médecine Interne. 13(7). S407–S407. 1 indexed citations
20.
Françès, C., et al.. (1979). Cytoplasmic differentiation antigens of human epidermal cells.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 27(6). 392–6. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026